Pivotal bioVenture Partners Fund I, L.P.

Insider Reports History

Location
501 Second Street, Suite 200, San Francisco, CA
Signature
/s/ Robert Hopfner - for Pivotal bioVenture Partners Fund I, L.P., By: Robert Hopfner, Managing Partner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pivotal bioVenture Partners Fund I, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Inozyme Pharma, Inc. Director Common Stock 1.57M $5.61M $3.57 Aug 1, 2023 Indirect
Evommune, Inc. Director, 10%+ Owner Common Stock 295K Nov 7, 2025 Indirect
Evommune, Inc. Director, 10%+ Owner Series A Preferred Stock 0 Nov 7, 2025 Indirect
Evommune, Inc. Director, 10%+ Owner Series B Preferred Stock 0 Nov 7, 2025 Indirect
Evommune, Inc. Director, 10%+ Owner Series C Preferred Stock 0 Nov 7, 2025 Indirect
Evommune, Inc. Director, 10%+ Owner Series Seed Preferred Stock 0 Nov 7, 2025 Indirect

Insider Reports Filed by Pivotal bioVenture Partners Fund I, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EVMN Evommune, Inc. Nov 7, 2025 12 $0 4 Nov 12, 2025 Director, 10%+ Owner
EVMN Evommune, Inc. Nov 5, 2025 0 $0 3 Nov 5, 2025 Director, 10%+ Owner
INZY Inozyme Pharma, Inc. Aug 1, 2023 2 $4M 4 Aug 3, 2023 Director
INZY Inozyme Pharma, Inc. Apr 19, 2022 1 $3.95M 4 Apr 20, 2022 Director